Jazz Pharmaceuticals plc (JAZZ) Net margin 2016–2025
Jazz Pharmaceuticals plc (JAZZ) net profit margin by fiscal year — reported net income divided by reported revenue.
-8.3%FY2025 · since FY2016: 26.7% → -8.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8.3% | -22.1 pp |
| FY2024 | 13.8% | +2.9 pp |
| FY2023 | 10.8% | +16.9 pp |
| FY2022 | -6.1% | +4.5 pp |
| FY2021 | -10.7% | -20.7 pp |
| FY2020 | 10.1% | -14.1 pp |
| FY2019 | 24.2% | +0.6 pp |
| FY2018 | 23.6% | -6.5 pp |
| FY2017 | 30.1% | +3.5 pp |
| FY2016 | 26.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice